Skip to main content
Log Out
My Account
Activate
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan
· Delayed Price · Currency is TWD
Full Chart
Watchlist
Alerts
Compare
60.90
0.00 (0.00%)
At close: Sep 2, 2026
Overview
Financials
Statistics
Dividends
History
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
Annual
Quarterly
TTM
TPEX:7806 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
TTM
Mil
Millions
Data
Data Source
TWD
TWD
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Revenue
535.88
538.65
435.08
Revenue Growth
-
23.80%
-
Cost of Revenue
392.66
374.88
296.89
Gross Profit
143.22
163.77
138.19
Selling, General & Admin
66.84
61.01
48.71
Research & Development
11.36
10.79
5.25
Other Operating Expenses
0.12
0.12
0.13
Operating Expenses
78.45
71.92
54.09
Operating Income
64.77
91.85
84.11
Interest Expense
-0.31
-2.27
-4.86
Interest & Investment Income
0.55
0.63
0.61
Other Non Operating Income (Expenses)
4.34
5
1.87
Pretax Income
69.36
95.21
81.72
Income Tax Expense
13.66
19.87
14.97
Net Income
55.7
75.33
66.75
Net Income to Common
55.7
75.33
66.75
Net Income Growth
-
12.85%
-
Shares Outstanding (Basic)
27
25
22
Shares Outstanding (Diluted)
27
25
22
Shares Change
-
11.74%
-
EPS (Basic)
2.08
3.05
3.04
EPS (Diluted)
2.08
3.04
3.01
EPS Growth
-
1.00%
-
Additional Metrics
TTM
Mil
Millions
Data
Data Source
TWD
TWD
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Free Cash Flow
-188.05
-234.66
-40.68
Free Cash Flow Per Share
-7.01
-9.47
-1.83
Gross Margin
26.73%
30.40%
31.76%
Operating Margin
12.09%
17.05%
19.33%
Profit Margin
10.39%
13.98%
15.34%
Free Cash Flow Margin
-35.09%
-43.56%
-9.35%
EBITDA
104.58
130.36
111.81
EBITDA Margin
19.52%
24.20%
25.70%
D&A For EBITDA
39.81
38.52
27.7
EBIT
64.77
91.85
84.11
EBIT Margin
12.09%
17.05%
19.33%
Effective Tax Rate
19.70%
20.87%
18.32%